Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer’s Disease
- 29 August 2017
- journal article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 60 (1) , 165-181
Abstract
Increasing evidence suggests that neuroinflammation comprises a major characteristic of Alzheimer’s disease (AD). Tumor necrosis factor-α (TNF-α) is a pleiotropic pro-inflammatory cytokine implicated in neurodegenerative diseases including AD, and haKeywords
This publication has 56 references indexed in Scilit:
- Treatment for Rheumatoid Arthritis and Risk of Alzheimer’s Disease: A Nested Case-Control AnalysisCNS Drugs, 2016
- Regulation of tumour necrosis factor signalling: live or let dieNature Reviews Immunology, 2015
- Immune attack: the role of inflammation in Alzheimer diseaseNature Reviews Neuroscience, 2015
- Neuroinflammation in Alzheimer's diseaseThe Lancet Neurology, 2015
- Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical LiteratureCold Spring Harbor Perspectives in Medicine, 2011
- Deciphering Alzheimer DiseaseCold Spring Harbor Perspectives in Medicine, 2011
- The role of microglia in amyloid clearance from the AD brainJournal of Neural Transmission, 2010
- Inflammation, microglia, and alzheimer's diseaseNeurobiology of Disease, 2010
- Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studiesBMJ, 2003
- Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's diseaseNeurology, 1996